INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings

Most active filers · 30d

  1. 01Kurtz George0B / 238S · 10 late238 trades$60.26M
  2. 02SPSaba Capital Management, L.P.58B / 21S · 3 late79 trades$24.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04CFCheng Chi Fung0B / 42S42 trades$15.33M
  5. 05RARothblatt Martine A0B / 33S33 trades$5.50M
  6. 06RJRubinstein Julie0B / 31S31 trades$5.54M
  7. 07LBLeach Bryan0B / 30S30 trades$7.97M
  8. 08AOAtay Oguzhan0B / 30S30 trades$7.55M
  9. 09JDJenkins William D Jr0B / 30S30 trades$13.38M
  10. 10BSBiswas Sanjit0B / 28S28 trades$22.33M
Data sources
SEC FORM 433m ago
HOUSE PTR33m ago
SEC 13F33m ago
ROBINHOOD CHAIN33m ago

Form 4 transactions

21,175 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
20
RE
Robinson ElliottDirector
HNGEHinge Health, Inc.
Open-market sale
SELL—
0 sh
Nov 4, 2026Nov 6, 2026
Page 6 of 530
← PrevNext →
traded Nov 4, 2026
+2d
SEC FORM 4

Evidence

20
RE
Robinson ElliottDirector
HNGEHinge Health, Inc.
Open-market sale
SELL—
0 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

20
RE
Robinson ElliottDirector
HNGEHinge Health, Inc.
Open-market sale
SELL—
0 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

20
RE
Robinson ElliottDirector
HNGEHinge Health, Inc.
Open-market sale
SELL—
0 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

20
RE
Robinson ElliottDirector
HNGEHinge Health, Inc.
Open-market sale
SELL—
0 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

20
RE
Robinson ElliottDirector
HNGEHinge Health, Inc.
Open-market sale
SELL—
0 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

20
Saba Capital Management, L.P.10% Owner
ECATBlackRock ESG Capital Allocation Term Trust
Open-market sale
SELL$466K
35.4K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

20
GJ
Gowans JasonEVP and CDTO
LEVILEVI STRAUSS & CO
Open-market sale
SELL$83K
3,494 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

20
RE
Robinson ElliottDirector
HNGEHinge Health, Inc.
Open-market sale
SELL—
0 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

20
RE
Robinson ElliottDirector
HNGEHinge Health, Inc.
Open-market sale
SELL—
0 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

19
PK
Patel Sanj KDirector, CHAIRMAN & CEO
KNSAKiniksa Pharmaceuticals International, plc
Open-market sale · 10b5-1 plan
SELL$2.85M
29.8K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

19
PK
Patel Sanj KDirector, CHAIRMAN & CEO
KNSAKiniksa Pharmaceuticals International, plc
Open-market sale · 10b5-1 plan
SELL$2.59M
26.9K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

19
GC
Goldberg ChenEVP, Product & Engineering
CRWVCoreWeave, Inc.
Open-market sale
SELL$32K
695 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

19
KA
King Ryan ADirector, Co-Founder
CHYMChime Financial, Inc.
Open-market sale · 10b5-1 plan
SELL$1.85M
59.0K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

19
PK
Patel Sanj KDirector, CHAIRMAN & CEO
KNSAKiniksa Pharmaceuticals International, plc
Open-market sale · 10b5-1 plan
SELL$1.06M
11.3K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

18
KM
Kansal MohitChief Payments Officer
FLYWFlywire Corp
Open-market sale · 10b5-1 plan
SELL$127K
6,053 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

18
ZM
Zerbe Robert L MdDirector
VCELVericel Corp
Open-market sale · 10b5-1 plan
SELL$129K
2,500 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

17
MK
McCulloch KevinSee Remarks
XERSXeris Biopharma Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$312K
25.0K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

17
PC
Pitigoi CosminChief Financial Officer
FLYWFlywire Corp
Open-market sale · 10b5-1 plan
SELL$301K
13.9K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

16
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$334K
585 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

16
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$321K
562 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

16
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$407K
720 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

16
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$293K
520 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

16
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$262K
462 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

16
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$311K
539 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

16
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$337K
560 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

16
DK
Dai KunDirector, Chief Executive Officer
UXINUxin Ltd
Open-market purchase · 10b5-1 plan
BUY$7,216
8,307 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

15
TF
Tan FionaChief Technology Officer
WWayfair Inc.
Open-market sale · 10b5-1 plan
SELL$1.00M
8,000 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

15
KT
Kelley Shannon TGeneral Counsel
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$431K
1,077 sh
Nov 6, 2026Nov 6, 2026
traded Nov 6, 2026
+0dSEC FORM 4

Evidence

15
PJ
Peters William JDirector, CFO, EVP & TREASURER
AMPHAmphastar Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$448K
16.0K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

15
CR
Corbin Charles R. Jr.See Remarks
HGVHilton Grand Vacations Inc.
Open-market sale · 10b5-1 plan
SELL$838K
19.6K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

14
FD
Fairbank Richard DDirector, Chairman and CEO
COFCAPITAL ONE FINANCIAL CORP
Open-market sale · 10b5-1 plan
SELL$1.07M
5,315 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

14
PC
Pitigoi CosminChief Financial Officer
FLYWFlywire Corp
Open-market sale · 10b5-1 plan
SELL$122K
5,916 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

14
JB
Jackson BenjaminPresident
ICEIntercontinental Exchange, Inc.
Open-market sale · 10b5-1 plan
SELL$71K
400 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC FORM 4

Evidence

14
TS
Tamari ShaharDirector, COO
GLBEGlobal-E Online Ltd.
Open-market sale · 10b5-1 plan
SELL$594K
13.4K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

14
TS
Tamari ShaharDirector, COO
GLBEGlobal-E Online Ltd.
Open-market sale · 10b5-1 plan
SELL$627K
14.0K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

14
FD
Fairbank Richard DDirector, Chairman and CEO
COFCAPITAL ONE FINANCIAL CORP
Open-market sale · 10b5-1 plan
SELL$1.05M
4,929 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

14
FD
Fairbank Richard DDirector, Chairman and CEO
COFCAPITAL ONE FINANCIAL CORP
Open-market sale · 10b5-1 plan
SELL$3.79M
18.8K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

14
FD
Fairbank Richard DDirector, Chairman and CEO
COFCAPITAL ONE FINANCIAL CORP
Open-market sale · 10b5-1 plan
SELL$1.67M
7,798 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

14
FD
Fairbank Richard DDirector, Chairman and CEO
COFCAPITAL ONE FINANCIAL CORP
Open-market sale · 10b5-1 plan
SELL$5.01M
24.6K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  3. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  4. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  5. SELLIBEXIBEX LtdSep 8 – Sep 166 insiders$2.66M
  6. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  7. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
  8. SELLBCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K